Latest Insider Transactions at Phio Pharmaceuticals Corp. (PHIO)
This section provides a real-time view of insider transactions for Phio Pharmaceuticals Corp. (PHIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Phio Pharmaceuticals Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Phio Pharmaceuticals Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Jonathan E Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+50.0%
|
-
|
|
Sep 11
2024
|
Robert M. Infarinato VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+21.43%
|
-
|
|
Sep 11
2024
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,500
+46.5%
|
-
|
|
Sep 11
2024
|
Patricia A Bradford Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Sep 11
2024
|
Robert L Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Sep 11
2024
|
Curtis Lockshin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|
|
Aug 13
2024
|
Robert M. Infarinato VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Jun 07
2024
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+4.55%
|
$0
$0.74 P/Share
|
|
Jun 06
2024
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+4.76%
|
$0
$0.75 P/Share
|
|
Mar 01
2024
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-3.05%
|
$0
$0.96 P/Share
|
|
Feb 26
2024
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+11.63%
|
$0
$0.91 P/Share
|
|
Feb 20
2024
|
Robert J Bitterman Chairman, Pres & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,804
-9.86%
|
$0
$0.76 P/Share
|
|
Feb 17
2024
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
523
-4.55%
|
$0
$0.66 P/Share
|
|
Feb 15
2024
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
658
-5.41%
|
$0
$0.65 P/Share
|
|
Oct 01
2023
|
Robert J Bitterman Chairman, Pres & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-4.77%
|
$917
$1.51 P/Share
|
|
Jul 01
2023
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+4.95%
|
$2,000
$2.84 P/Share
|
|
Jun 30
2023
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+5.21%
|
$2,000
$2.88 P/Share
|
|
Jun 14
2023
|
Robert L Ferrara Director |
BUY
Open market or private purchase
|
Direct |
2,000
+25.0%
|
$6,000
$3.1 P/Share
|
|
Mar 01
2023
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-2.68%
|
$1,675
$5.49 P/Share
|
|
Feb 20
2023
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+38.99%
|
-
|
|
Feb 17
2023
|
Curtis Lockshin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+31.94%
|
-
|
|
Feb 17
2023
|
Jonathan E Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+31.94%
|
-
|
|
Feb 17
2023
|
Robert L Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+27.27%
|
-
|
|
Feb 17
2023
|
Geert Cauwenbergh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+26.16%
|
-
|
|
Feb 17
2023
|
Patricia A Bradford Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+32.14%
|
-
|
|
Feb 17
2023
|
Caitlin Kontulis Secretary & VP Finance & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
4,500
+26.48%
|
-
|
|
Feb 15
2023
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
657
-7.59%
|
$3,285
$5.2 P/Share
|
|
Dec 14
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+2.61%
|
$0
$0.39 P/Share
|
|
Dec 07
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+2.68%
|
$0
$0.39 P/Share
|
|
Dec 05
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+2.76%
|
$0
$0.43 P/Share
|
|
Dec 02
2022
|
Robert L Ferrara Director |
BUY
Open market or private purchase
|
Direct |
5,000
+14.29%
|
$0
$0.41 P/Share
|
|
Nov 29
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
215
+0.31%
|
$0
$0.4 P/Share
|
|
Nov 25
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+3.53%
|
$0
$0.42 P/Share
|
|
Nov 23
2022
|
Robert L Ferrara Director |
BUY
Open market or private purchase
|
Direct |
2,000
+7.41%
|
$0
$0.41 P/Share
|
|
Nov 16
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Open market or private purchase
|
Direct |
1
+50.0%
|
$1,750
$1750.0 P/Share
|
|
Oct 01
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+37.8%
|
-
|
|
Aug 09
2022
|
Patricia A Bradford Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+50.0%
|
-
|
|
Mar 01
2022
|
Gerrit Dispersyn President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,954
-4.05%
|
$0
$0.82 P/Share
|
|
Mar 01
2022
|
Caitlin Kontulis Secretary & VP Finance & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
4,011
-3.72%
|
$0
$0.82 P/Share
|
|
Feb 15
2022
|
Robert J Bitterman Chairman, Pres & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+27.91%
|
-
|
|
Feb 15
2022
|
Geert Cauwenbergh Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+23.35%
|
-
|
|
Feb 15
2022
|
Gerrit Dispersyn President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
126,000
+36.28%
|
-
|
|
Feb 15
2022
|
H. Paul Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.93%
|
-
|
|
Feb 15
2022
|
Robert L Ferrara Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+30.3%
|
-
|
|
Feb 15
2022
|
Jonathan E Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.93%
|
-
|
|
Feb 15
2022
|
Caitlin Kontulis Secretary & VP Finance & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
68,000
+38.67%
|
-
|
|
Feb 15
2022
|
Curtis Lockshin Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+32.93%
|
-
|
|
Aug 16
2021
|
Gerrit Dispersyn President & CEO |
BUY
Open market or private purchase
|
Direct |
6,000
+5.92%
|
$6,000
$1.63 P/Share
|
|
Mar 04
2021
|
Gerrit Dispersyn President & CEO |
BUY
Open market or private purchase
|
Direct |
1,953
+2.14%
|
$3,906
$2.56 P/Share
|
|
Mar 03
2021
|
Gerrit Dispersyn President & CEO |
BUY
Open market or private purchase
|
Direct |
2,500
+2.78%
|
$7,500
$3.03 P/Share
|